MINUTES OF PROCEEDINGS
TUESDAY, APRIL 8, 1997
(Meeting No. 59)
(Meeting No. 59)
[Text]
The Standing Committee on Industry met in a televised session at 4:12 o'clock p.m. this day, in Room 253-D, Centre Block, the Chairman, David Walker, presiding.
Members of the Committee present: Morris Bodnar, Pierre Brien, Bonnie Brown, Nick Discepola, Walt Lastewka, Philip Mayfield, Réal Ménard, Ian Murray, Bernard Patry, Werner Schmidt, Joseph Volpe and David Walker.
Associate Member present: Joe Fontana.
Other Members present: Carolyn Parrish and Nic Leblanc.
In attendance: From the Research Branch of the Library of Parliament: Antony Jackson and Daniel Brassard, Research Officers.
Witnesses: From the Board of Trade of Metropolitan Toronto: David McFadden, Q.C., Vice-President. From the Board of Trade of Metropolitan Montreal: Luc Lacharité, Executive Vice-President. From Map International of Canada: John P. Kelsall, President; Robert Stephens, MD, Board of Directors and Executive Director of the Christian Medical and Dental Society of Canada and Evangelical Medical Aid Society of Canada. From Novopharm Limited: Jacques Messier, President and Chief Operating Officer; David Windross, Director, Government & Professional Affairs; David Howard, President, Stanley Pharmaceuticals Ltd. From «Groupement provincial de l'industrie du médicament»: Pierre Morin, General Manager; and André Boivin, President of ProDoc Laboratories Inc. (Laval). From Canada's New Democrats: Alexa McDonough, Leader; From Canadian Pharmaceutical Association: Garry Cruickshank, Vice-President; Noëlle-Dominique Willems, Director of Government and Public Affairs. From the Quebec Research Group on Medication Use on the Elderly: Robyn Tamblyn. From the University of British Columbia: James M. Wright, MD, PhD, FRCP(C), Department of Pharmacology & Therapeutics. From Grey Clark Shih and Associates: Peter Clark, President.
In accordance with its mandate under Standing Order 108(2), the Committee resumed its review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993) (See Minutes of Proceedings dated Monday, February 17, 1997, Issue No. 4 -- Meeting No. 42).
David McFadden, John Kelsall, Robert Stephens, Jacques Messier, David Howard and Pierre Morin, each made a statement and answered questions.
At 5:33 o'clock p.m., the Vice-Chair, Walt Lastewka, took the Chair.
The witnesses continued answering questions.
At 5:48 o'clock p.m, the sitting was suspended.
At 5:49 o'clock p.m., the sitting resumed.
Alexa McDonough, Garry Cruickshank, Robyn Tamblyn, James Wright and Peter Clark, each made a statement and, with the other witnesses, answered questions.
At 7:23 o'clock p.m., the Committee adjourned until 7:30 o'clock p.m. this day.
TUESDAY, APRIL 8, 1997
(Meeting No. 60)
(Meeting No. 60)
The Standing Committee on Industry met in a televised session at 7:43 o'clock p.m. this day, in Room 253-D, Centre Block, the Vice-Chair, Walt Lastewka, presiding.
Members of the Committee present: Morris Bodnar, Pierre Brien, Bonnie Brown, Walt Lastewka, Philip Mayfield, Ian Murray, Bernard Patry, Werner Schmidt and Joseph Volpe.
Other Member present: Carolyn Parrish.
In attendance: From the Research Branch of the Library of Parliament: Antony Jackson, Research Officer.
Witnesses: From Lenczner Slaght Royce Smith Griffin: Ronald Slaght, Q.C., Lawyer; Tim Gilbert, Lawyer. From Goodman Phillips & Vineberg: Jon R. Johnson. From the Law Union of Ontario: Michael Halewood. From McCarthy Tétrault, Barristers & Solicitors: Peter S. Martin, Partner. From the Royal Canadian Legion: James Rycroft, Coordinating Secretary, Legion Seniors and Veterans Services Committees. From «Confédération des syndicats nationaux»: Pierre Paquette, Secretary General of the CSN; Andrée Lapierre, Advisor, Research Services. From Citizens Concerned About Free Trade: David Orchard, Chair. From the National Federation of Nurses Unions: Kathleen Connors, President; Margaret McCoy, National Officer, Professional Institute of the Public Service of Canada. From the Canadian Labour Congress: Bob White, President; Cindy Wiggins, Senior Researcher; and Michael McBane, Co-ordinator, Canadian Health Coalition. From the University of Alberta, Edmonton: D. Lorne J. Tyrrell, MD PhD. From Queen's Health Policy Research Unit: Malcolm Anderson, Senior Associate; From JGH Consulting Inc.: James G. Heller.
In accordance with its mandate under Standing Order 108(2), the Committee resumed its review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993) (See Minutes of Proceedings dated Monday, February 17, 1997, Issue No. 4, Meeting No. 42).
Ronald Slaght, Jon Johnson, Michael Halewood and Peter Martin, each made a statement and, with the other witness, answered question.
At 9:01 o'clock p.m., the sitting was suspended.
At 9:04 o'clock p.m., the sitting resumed.
James Rycroft, Pierre Paquette, David Orchard, Kathleen Connors, and Bob White, each made a statement and, with the other witnesses, answered questions.
At 10:07 o'clock p.m., the sitting was suspended.
At 10:09 o'clock p.m., the sitting resumed.
D. Lorne J. Tyrrell, Malcolm Anderson and James G. Heller, each made a statement and answered questions.
At 11:10 o'clock p.m., the Committee adjourned to the call of the Chair.
WEDNESDAY, APRIL 9, 1997
(Meeting No. 61)
(Meeting No. 61)
The Standing Committee on Industry met in a televised session at 4:08 o'clock p.m. this day, in Room 253-D, Centre Block, the Chairman, David Walker, presiding.
Members of the Committee present: Morris Bodnar, Pierre Brien, Bonnie Brown, Walt Lastewka, Réal Ménard, Ian Murray, Bernard Patry, Werner Schmidt and David Walker.
In attendance: From the Research Branch of the Library of Parliament: Antony Jackson and Daniel Brassard, Research Officers.
Witnesses: From the National Forum on Health: Tom W. Noseworthy, Member, Professor and Chair of the Department of Public Health Sciences, University of Alberta; Robert G. Evans, Member, Professor of Economics, University of British Columbia. From «COCQ-SIDA»: Alain Godmaire, Secretary of the Board; Jean-Pierre Bélisle, Representative of persons living with HIV/AIDS. From the Canadian AIDS Society: Rodney Kort, Program Consultant. From the Canadian Treatment Advocates Council: Louise Binder, Co-Chair; Wayne Moore, Member of the Board. From the Canadian HIV Trials Network: William Cameron, Regional Director (Ontario). From the Consumers' Association of Canada: Marnie McCall, Director of Policy Research & Executive Director (Acting); Christine Miskell, Research Associate; Jean Jones, Chair, National Health Council; André Ouellette, Trade Policy Analyst. From the National Federation of the Consumer's Association of Quebec: Nancy Trépanier, Consumer's adviser of ACEF Rive-Sud and Spokesperson for the FNACQ's Health Committee; Anne-Marie Tassé, Spokesperson for ACEF Estrie and Member of the FNACQ's Health Committee. From the Arthritis Society: Denis Morrice, President & CEO. As individual: Linda Kemp, R.N. From Faith Partners: Murray Angus, Spokesperson; and Ron Chaplin, Spokesperson.
In accordance with its mandate under Standing Order 108(2), the Committee resumed its review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993) (See Minutes of Proceedings dated Monday, February 17, 1997, Issue No. 4, Meeting No. 42).
Tom W. Noseworthy and Robert G. Evans, each made a statement and answered questions.
At 5:22 o'clock p.m., the sitting was suspended.
At 6:26 o'clock p.m., the sitting resumed.
At 6:26 o'clock p.m., the Vice-Chair, Walt Lastewka, took the Chair.
Alain Godmaire, Rodney Kort, Louise Binder and William Cameron, each made a statement and, with the other witnesses, answered questions.
At 7:37 o'clock p.m., the sitting was suspended.
At 7:42 o'clock p.m., the sitting resumed.
Marnie McCall and Nancy Trépanier, each made a statement and, with the other witnesses, answered questions.
At 8:40 o'clock p.m., the sitting was suspended.
At 8:45 o'clock p.m., the sitting resumed.
Denis Morrice, Linda Kemp, Murray Angus and Ron Chaplin, each made a statement and answered questions.
At 9:29 o'clock p.m., the Committee adjourned to the call of the Chair.
THURSDAY, APRIL 10, 1997
(Meeting No. 62)
(Meeting No. 62)
The Standing Committee on Industry met in a televised session at 10:37 o'clock a.m. this day, in Room 253-D, Centre Block, the Vice-Chair, Walt Lastewka, presiding.
Members of the Committee present: Morris Bodnar, Pierre Brien, Bonnie Brown, Walt Lastewka, Ian Murray, Werner Schmidt and Joseph Volpe.
Other Member present: Carolyn Parrish.
In attendance: From the Research Branch of the Library of Parliament: Antony Jackson and Margaret Smith, Research Officers.
Witnesses: From Gowling, Strathy and Henderson: Emma Grell, Partner. From Hazzard and Hore: Edward Hore, Lawyer. From Osgoode Hall Law School: David Vaver, Professor.
In accordance with its mandate under Standing Order 108(2), the Committee resumed its review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993) (See Minutes of Proceedings dated Monday, February 17, 1997, Issue No. 4, Meeting No. 42).
David Vaver, Emma Grell and Edward Hore, each made various statements and answered questions.
At 12:08 o'clock p.m., the sitting was suspended.
At 12:20 o'clock p.m., the sitting resumed.
The witnesses resumed making statements and answering questions.
At 12:41 o'clock p.m., the Committee adjourned to the call of the Chair.
THURSDAY, APRIL 10, 1997
(Meeting No. 63)
(Meeting No. 63)
The Standing Committee on Industry met at 3:33 o'clock p.m. this day, in Room 237-C, Centre Block, the Vice-Chair, Walt Lastewka, presiding.
Members of the Committee present: Morris Bodnar, Pierre Brien, Bonnie Brown, Walt Lastewka, Bernard Patry, Werner Schmidt and Joseph Volpe.
In attendance: From the Research Branch of the Library of Parliament: Antony Jackson and Margaret Smith, Research Officers.
Witnesses: From the Government of Manitoba: The Hon. Darren Praznik, Minister of Health; Ulrich Wendt, Healthy Communities Office, Manitoba Health; Nigel Lilley, Health Industry Development, Manitoba Industry, Trade and Tourism; Deborah Vivian, Policy Management Secretariat, Executive Council -- Manitoba. From Gowling, Strathy and Henderson: Emma Grell, Partner. From Hazzard and Hore: Edward Hore, Lawyer. From Osgoode Hall Law School: David Vaver, Professor.
In accordance with its mandate under Standing Order 108(2), the Committee resumed its review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993) (See Minutes of Proceedings dated Monday, February 17, 1997, Issue No. 4, Meeting No. 42).
The Hon. Darren Praznik made a statement and answered questions.
David Vaver, Emma Grell and Edward Hore made various statements and answered questions.
At 6:10 o'clock p.m., the Committee adjourned to the call of the Chair.
TUESDAY, APRIL 15, 1997
(Meeting No. 64)
The Evidence for this meeting is not available because it was held in camera.
(Meeting No. 64)
The Evidence for this meeting is not available because it was held in camera.
The Standing Committee on Industry met in camera at 3:32 o'clock p.m. this day, in Room 705, La Promenade, the Chair, David Walker, presiding.
Members of the Committee present: Morris Bodnar, Pierre Brien, Bonnie Brown, Nick Discepola, Walt Lastewka, Ian Murray, Bernard Patry, Joseph Volpe and David Walker.
Acting Members present: Gar Knutson for Ron MacDonald; and Grant Hill for Philip Mayfield.
Other Member present: Carolyn Parrish.
In attendance: From the Research Branch of the Library of Parliament: Margaret Smith, Nathalie Pothier and Antony Jackson, Research Officers.
Pursuant to Standing Order 108(2), the Committee resumed its review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993) (See Minutes of Proceedings dated Monday, February 17, 1997, Issue No. 4, Meeting No. 42).
On motion of Morris Bodnar, it was agreed,--That the Committee retain the services of David Vaver, as consultant, to assist in its consideration of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993), from April 8th to 30th, 1997 for an amount not to exceed $3,000.
On motion of Morris Bodnar, it was agreed,--That the Chairman be authorized to submit a supplementary budget to the Budget Sub-Committee of the Liaison Committee in the amount of $79,000.
The Committee proceeded to discuss the draft report.
At 4:08 o'clock p.m., the Committee adjourned to the call of the Chair.
THURSDAY, APRIL 17, 1997
(Meeting No. 65)
(Meeting No. 65)
The Standing Committee on Industry met in a televised session at 11:32 o'clock a.m. this day, in Room 253-D, Centre Block, the Vice-Chair, Pierre Brien, presiding.
Members of the Committee present: Morris Bodnar, Pierre Brien, Bonnie Brown, Réal Ménard, Ian Murray, Bernard Patry and Joseph Volpe.
Acting Member present: Grant Hill for Werner Schmidt.
In attendance: From the Research Branch of the Library of Parliament: Nathalie Pothier and Antony Jackson, Research Officers.
Witnesses: From the Government of Saskatchewan: Hon. Eric Cline, Minister of Health; Glenda Yeates, Associate Deputy Minister; Kevin Wilson, Director, Pharmaceutical Services, Saskatchewan Drug Plan. From the Government of British Columbia: Hon. Joy K. MacPhail, Minister of Health; Anne McFarlane, Director, Pharmacare, Ministry of Health and Ministry Responsible for Seniors; Dr. Rick Hudson, Director, Clinical Support Unit, Ministry of Health and Ministry Responsible for Seniors.
Pursuant to Standing Order 108(2), the Committee resumed its review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993) (See Minutes of Proceedings dated Monday, February 17, 1997, Issue No. 4, Meeting No. 42).
The Hon. Eric Cline made a statement and answered questions.
At 12:32 o'clock p.m., the sitting was suspended.
At 12:38 o'clock p.m., the sitting resumed.
The Hon. Joy K. MacPhail made a statement and with the other witnesses from the Government of British Columbia, answered questions.
At 1:36 o'clock p.m., the Committee adjourned to the call of the Chair.
Susan Baldwin
Clerk of the Committee